Stockscreener 앱 받기
1.45%
시간 외 거래:
Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to unlock new upside? - AD HOC NEWS
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
What to Expect From Amgen's Next Quarterly Earnings Report - Barchart
Amgen Inc. stock (US0311621009): Is its obesity drug pipeline strong enough to unlock new upside? - AD HOC NEWS
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to drive new upside? - AD HOC NEWS
Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer - GlobeNewswire Inc.
Pfizer (PFE) and Amgen (AMGN) Expand Presence in Hong Kong - GuruFocus
Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
Amgen Inc. Trade Ideas — LSE:0R0T - TradingView
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to drive sustained upside? - AD HOC NEWS
Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy - Insider Monkey
Wealth Enhancement Trust Services Inc. Takes $1.58 Million Position in Amgen Inc. $AMGN - MarketBeat
Is It Time To Reconsider Amgen (AMGN) After Its Strong Multi Year Share Price Run? - Yahoo Finance
Oak Harvest Investment Services Reduces Stake in Amgen Inc. $AMGN - MarketBeat
GF Fund Management CO. LTD. Acquires 6,216 Shares of Amgen Inc. $AMGN - MarketBeat
Asset Management One Co. Ltd. Has $114.31 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Laps the Stock Market: Here's Why - Yahoo Finance Singapore
AMGEN INC: SUBMITS SEC FILING FOR COMMON STOCK OFFERING BY SELLING SECURITYHOLDERS - Intellectia AI
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 - Insider Monkey
Amgen Inc. $AMGN Shares Sold by Whittier Trust Co. - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $186.70 Million Stake in Amgen Inc. $AMGN - MarketBeat
Assessing Whether Amgen (AMGN) Still Looks Undervalued After Recent Share Price Pullback - simplywall.st
Argo Wealth Advisory LLC Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
AE Wealth Management LLC Has $43.90 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
Idiopathic Pulmonary Fibrosis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GSK, Amgen, Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant - Barchart.com
Amgen Shares Acquired by Lbp Am Sa - National Today
Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Eli Lilly and Company, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories, Amgen, Teva Pharma, Anne Lindblad - Barchart.com
KBC Group NV Has $187.27 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Lbp Am Sa - MarketBeat
Amgen Extends Cuala GAA Title Sponsorship Through 2029 - Sport for Business
Amgen Inc. $AMGN Shares Purchased by Farther Finance Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Cwm LLC - MarketBeat
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen Inc. stock (US0311621009): Is its biotech innovation edge strong enough for steady gains? - AD HOC NEWS
2 Reasons to Like AMGN and 1 to Stay Skeptical - Yahoo Finance
Amgen Inc. stock (US0311621009): Is its biotech innovation edge strong enough to unlock new upside? - AD HOC NEWS
Amgen And Zai Lab Trial Tests DLL3 Combo As Valuation Looks Undemanding - Yahoo Finance
Amgen Inc. stock (US0311621009): Is obesity drug momentum strong enough to sustain long-term growth? - AD HOC NEWS
Amgen And Zai Lab DLL3 Alliance Adds New Dimension To Oncology Story - simplywall.st
Assetmark Inc. Increases Stake in Amgen Inc. - National Today
Assetmark Inc. Buys 14,341 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
AMGN Maintained by UBS -- Price Target Raised to $400 - GuruFocus
Amgen (NASDAQ:AMGN) Price Target Raised to $400.00 - MarketBeat
Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength - Insider Monkey
‘Community Day Presented by Amgen’ Mobilizes Volunteers to Touch Up Greater Los Angeles Ahead of FIFA World Cup 2026 - Amgen
Beat the Market the Zacks Way: FirstEnergy, Seanergy Maritime, Amgen in Focus - Yahoo Finance
HBW Advisory Services LLC Has $2.07 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Settles Denosumab Biosimilar Lawsuits with Henlius and Organon - National Today
Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug - Mugglehead Investment Magazine
Sumitomo Mitsui Trust Group Reduces Stake in Amgen - National Today
Kelsey Financial LLC Makes New $7.13 Million Investment in Amgen Inc. $AMGN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $527.74 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Robeco Institutional Asset Management B.V. Increases Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by KG&L Capital Management LLC - MarketBeat
Curtis Advisory Group Adds Amgen Shares to Portfolio - National Today
Curtis Advisory Group LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
0.15%
자본화:
|
볼륨(24시간):